**Core Concept**
α1-antitrypsin deficiency is a genetic disorder characterized by a deficiency of the α1-antitrypsin protein, which is primarily produced in the liver. This protein plays a crucial role in protecting the lungs from the enzyme neutrophil elastase, thereby preventing lung damage.

**Why the Correct Answer is Right**
The correct answer is associated with chronic obstructive pulmonary disease (COPD) due to the imbalance between the proteolytic activity of neutrophil elastase and the inhibitory activity of α1-antitrypsin. When α1-antitrypsin levels are low, neutrophil elastase can cause excessive degradation of lung tissue, leading to emphysema and COPD. This pathophysiological process is a classic example of an imbalance between proteolysis and antiproteolysis.

**Why Each Wrong Option is Incorrect**
**Option A:** Emphysema is correct but incomplete, as it only describes a symptom of the disease; α1-antitrypsin deficiency is associated with a broader range of clinical manifestations.
**Option B:** Liver disease is incorrect because, although α1-antitrypsin deficiency can cause liver damage, it is not the primary association.
**Option C:** Pancreatitis is incorrect because α1-antitrypsin deficiency is not directly associated with pancreatitis.

**Clinical Pearl / High-Yield Fact**
α1-antitrypsin deficiency is often referred to as a "genetic predisposition to COPD," and it is essential to consider this diagnosis in patients with early-onset COPD or those with a strong family history of lung disease.

**Correct Answer:** C.